Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberley V Walburg

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|December 13, 2021
Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease <i>Mycobacterium tuberculosis</i> Survival in Human MacrophagesCassandra L R van Doorn, Sanne A M Steenbergen, Kimberley V Walburg, et al.
Carcinogenesis|May 27, 2006
Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activityCarina L Bos, Sander H Diks, James C H Hardwick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1Nigel D L Savage, Tjitske de Boer, Kimberley V Walburg, et al.
Journal of Innate Immunity|December 31, 2025
Prior exposure of airway epithelial cells to mycobacteria reduces subsequent Mycobacterium tuberculosis infection and resulting inflammationAmy M Barclay, Dennis K Ninaber, Kimberley V Walburg, et al.
STAR Protocols|June 6, 2025
Protocol to infect differentiated human primary bronchial epithelial cells with live mycobacteria and determine intracellular loadAmy M Barclay, Kimberley V Walburg, Dennis K Ninaber, et al.
Frontiers in Cellular and Infection Microbiology|July 11, 2022
Development of Human Cell-Based <i>In Vitro</i> Infection Models to Determine the Intracellular Survival of <i>Mycobacterium avium</i>Gül Kilinç, Kimberley V Walburg, Kees L M C Franken, et al.
Frontiers in Immunology|September 23, 2021
Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Improves Host Control of <i>Salmonella enterica</i> Serovar Typhimurium Infection in Human MacrophagesCassandra L R van Doorn, Gina K Schouten, Suzanne van Veen, et al.
Vaccines|June 24, 2022
Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human MacrophagesCarina C Dos Santos, Kimberley V Walburg, Suzanne van Veen, et al.
Iscience|November 6, 2024
Mycobacteria develop biofilms on airway epithelial cells and promote mucosal barrier disruptionAmy M Barclay, Dennis K Ninaber, Ronald W A L Limpens, et al.
Investigative Ophthalmology & Visual Science|April 7, 2018
Retinal Pigment Epithelial Cells Control Early Mycobacterium tuberculosis Infection via Interferon SignalingRina La Distia Nora, Kimberley V Walburg, P Martin van Hagen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|December 13, 2021
Pharmacological Poly (ADP-Ribose) Polymerase Inhibitors Decrease <i>Mycobacterium tuberculosis</i> Survival in Human MacrophagesCassandra L R van Doorn, Sanne A M Steenbergen, Kimberley V Walburg, et al.
Carcinogenesis|May 27, 2006
Protein phosphatase 2A is required for mesalazine-dependent inhibition of Wnt/beta-catenin pathway activityCarina L Bos, Sander H Diks, James C H Hardwick, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1Nigel D L Savage, Tjitske de Boer, Kimberley V Walburg, et al.
Journal of Innate Immunity|December 31, 2025
Prior exposure of airway epithelial cells to mycobacteria reduces subsequent Mycobacterium tuberculosis infection and resulting inflammationAmy M Barclay, Dennis K Ninaber, Kimberley V Walburg, et al.
STAR Protocols|June 6, 2025
Protocol to infect differentiated human primary bronchial epithelial cells with live mycobacteria and determine intracellular loadAmy M Barclay, Kimberley V Walburg, Dennis K Ninaber, et al.
Frontiers in Cellular and Infection Microbiology|July 11, 2022
Development of Human Cell-Based <i>In Vitro</i> Infection Models to Determine the Intracellular Survival of <i>Mycobacterium avium</i>Gül Kilinç, Kimberley V Walburg, Kees L M C Franken, et al.
Frontiers in Immunology|September 23, 2021
Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Improves Host Control of <i>Salmonella enterica</i> Serovar Typhimurium Infection in Human MacrophagesCassandra L R van Doorn, Gina K Schouten, Suzanne van Veen, et al.
Vaccines|June 24, 2022
Recombinant BCG-LTAK63 Vaccine Candidate for Tuberculosis Induces an Inflammatory Profile in Human MacrophagesCarina C Dos Santos, Kimberley V Walburg, Suzanne van Veen, et al.
Iscience|November 6, 2024
Mycobacteria develop biofilms on airway epithelial cells and promote mucosal barrier disruptionAmy M Barclay, Dennis K Ninaber, Ronald W A L Limpens, et al.
Investigative Ophthalmology & Visual Science|April 7, 2018
Retinal Pigment Epithelial Cells Control Early Mycobacterium tuberculosis Infection via Interferon SignalingRina La Distia Nora, Kimberley V Walburg, P Martin van Hagen, et al.
Pageof 2